NAPSR News: FDA Approves Eli Lilly Diabetes Drug Trulicity™

WASHINGTON - Sept. 19, 2014 - PRLog -- The U.S. Food and Drug Administration (FDA) has approved Trulicity™ (dulaglutide) developed by Eli Lilly which represents the first approval of this drug anywhere in the world. Trulicity™ is intended to treat Type 2 Diabetes in adult patients. Trulicity™ will be  administered using a single-dose pen that does not require mixing nor measuring and comes with a no-see, no-handle needle.

Trulicity™  should  be used  with proper diet and exercise thus improving the blood sugar (glucose) control in  adult patients with type 2 diabetes and not recommended as a first line therapy for patients inadequately controlled on diet and exercise.

"We are delighted with the approval of Trulicity™. Lilly now has treatment options in several classes of diabetes medications: orals, GLPs and insulin," said Enrique Conterno, president, Lilly Diabetes. "Trulicity will help grow the GLP-1 receptor agonist class as a new choice for adults with type 2 diabetes."

Eli Lilly plans to launch Trulicity™ later this year in the form of .75 mg and 1.5 mg single-dose pens .

CANDIDATES WHO WANT TO BREAK INTO PHARMACEUTICAL SALES!
The CNPR is a federally trademarked certification you can earn by demonstrating the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPR examination is dedicated to increasing the professional level of NAPSR members and to developing meaningful and ethical standards fully accepted by both its members and members of the pharmaceutical community.

The CNPR® Program represents a level of industry achievement and a demonstrated knowledge of pharmacology, medical terminology, pharmaceutical selling guidelines, physician selling techniques and industry standards. Pharmaceutical sales candidates who have this training will differentiate themselves from other individuals looking for open positions. Upon successful completion of the training each student will receive the Certification Mark of the CNPR®. CNPR® graduates should immediately utilize the NAPSRx® Career Center to apply for pharmaceutical sales positions.

Individuals that are interested in becoming a Certified National Pharmaceutical Representative (CNPR) can contact the National Association of Pharmaceutical Sales Representatives(NAPSRx) for more information or visit the website at http://napsronline.org/